Author

Gopinath Rongala

Institution: VenatoRx Pharmaceuticals (United States)

Observed institution: VenatoRx Pharmaceuticals (United States)

ORCID: 0000-0001-9459-648X

Observed ORCID: 0000-0001-9459-648X

OpenAlex ID: A5115691528

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization

2022 · Srushti Tambe, Divya Jain, et al. · Pharmaceutics · 145

A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeae

2026 · Tsuyoshi Uehara, Allison L. Zulli, et al. · Nature Microbiology · 4

Works count: 2

Citation count: 149

H-index: 2

I10-index: 1